Oviva Therapeutics addresses the vast unmet need in women's health by expanding funding, research and clinical development of treatments addressing female physiology, beginning with a focus on ovarian aging.
There aren’t many biotechs emphasizing women’s health, but a new spinout is trying to change that.
Oviva Therapeutics just raised $11.5 million to develop drugs based on the work of Mass. General researchers.
Led by Daisy Robinton, PhD, Oviva aims to improve ovarian health and extend female healthspan through therapeutic innovation
The field of female reproductive longevity and inequality is getting more and more attention.
Leaders in the fertility industry discuss male fertility treatment, menopause and the latest breakthroughs giving people new ways to become parents.
This study aims to identify drugs that activate the Mullerian inhibiting substance pathway to be used for contraception or other applications in women’s health.
A $25 million prize awaits the discoverer of a nonsurgical sterilant for dogs and cats, but reproductive biology is complicated.
We hear from David, Associate Director of the Pediatric Surgical Research Laboratories of the Massachusetts General Hospital, and an Associate Professor of Surgery at Harvard Medical School, who speaks to the award-winning project seeking to extend the reproductive longevity and hormonal health of women as they age.
This biotech CEO wants to slow women’s aging by extending ovulation.
Cambrian’s Dr. Daisy Robinton on the basis of sex, ovarian aging and improving clinical trials and education.
One of the world’s most influential reproductive scientists, Patricia Kilroy Donahoe, MD, FACS, in June received the 2021 Jacobson Innovation Award of the American College of Surgeons (ACS) during a virtual event.
The end of the pandemic is tantalisingly close, but what about the next pandemic? Have we learnt enough to prevent it from happening?
Biomedical research and healthcare are plagued by historic sex and gender disparities. But a new dawn is on the horizon — and we’re running towards it at full speed. Watch this conversation between Daisy Robinton and Jennifer Garrison.
The group includes women who are driving innovation in therapeutics, diagnostics, sustainable foods and more.
Designed to fund early-career scientists at the peak of their creativity and inventiveness, Michelson Prizes and research grants underwrite bold, blue-sky ideas.